Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 3
2021 5
2022 7
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Evaluation of HIV-1 integrase variability by combining computational and probabilistic approaches.
Vergni D, Santoni D, Bouba Y, Lemme S, Fabeni L, Carioti L, Bertoli A, Gennari W, Forbici F, Perno CF, Gagliardini R, Ceccherini-Silberstein F, Santoro MM; HIV drug-resistance group. Vergni D, et al. Among authors: bouba y. Infect Genet Evol. 2022 Jul;101:105294. doi: 10.1016/j.meegid.2022.105294. Epub 2022 May 2. Infect Genet Evol. 2022. PMID: 35513162 Free article.
Factors Associated with Low-Level Viremia in People Living with HIV in the Italian Antiviral Response Cohort Analysis Cohort: A Case-Control Study.
Lombardi F, Bruzzesi E, Bouba YR, Di Carlo D, Costabile V, Ranzenigo M, Maggiolo F, Castagna A, Callegaro AP, Zoncada A, Paolucci S, Micheli V, Renica S, Bezencheck A, Rossetti B, Santoro MM. Lombardi F, et al. Among authors: bouba yr. AIDS Res Hum Retroviruses. 2024 Feb;40(2):80-89. doi: 10.1089/AID.2023.0015. Epub 2023 Jul 14. AIDS Res Hum Retroviruses. 2024. PMID: 37345697
Predictors of Virological Failure Among People Living with HIV Switching from an Effective First-Line Antiretroviral Regimen.
Magnasco L, Pincino R, Pasculli G, Bouba Y, Saladini F, Bavaro DF, De Vito A, Lattanzio R, Corsini R, Zazzi M, Incardona F, Rossetti B, Bezenchek A, Borghi V, Di Biagio A. Magnasco L, et al. Among authors: bouba y. AIDS Res Hum Retroviruses. 2022 Jun;38(6):463-471. doi: 10.1089/AID.2021.0016. Epub 2022 Feb 10. AIDS Res Hum Retroviruses. 2022. PMID: 34969260
Early versus delayed antiretroviral therapy based on genotypic resistance test: Results from a large retrospective cohort study.
Bavaro DF, De Vito A, Pasculli G, Bouba Y, Magnasco L, Pincino R, Saladini F, Lattanzio R, Corsini R, Arima S, Zazzi M, Incardona F, Rossetti B, Bezenchek A, Vanni B, Di Biagio A. Bavaro DF, et al. Among authors: bouba y. J Med Virol. 2022 Aug;94(8):3890-3899. doi: 10.1002/jmv.27754. Epub 2022 Apr 9. J Med Virol. 2022. PMID: 35355293 Free PMC article.
Evaluation of HIV-1 capsid genetic variability and lenacapavir (GS-6207) drug resistance-associated mutations according to viral clades among drug-naive individuals.
Nka AD, Bouba Y, Teto G, Semengue ENJ, Takou DK, Ngueko AMK, Fabeni L, Carioti L, Armenia D, Pabo W, Dambaya B, Sosso SM, Colizzi V, Perno CF, Ceccherini-Silberstein F, Santoro MM, Fokam J, Ndjolo A. Nka AD, et al. Among authors: bouba y. J Antimicrob Chemother. 2022 Dec 23;78(1):272-275. doi: 10.1093/jac/dkac388. J Antimicrob Chemother. 2022. PMID: 36411257
24 results